These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6762935)

  • 1. Antilymphoblast globulin for treatment of acute renal allograft rejection.
    Streem SB; Novick AC; Braun WE; Steinmuller DR
    Cleve Clin Q; 1982; 49(4):219-24. PubMed ID: 6762935
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of antilymphoblast globulin in the treatment of renal allograft rejection.
    Howard RJ; Condie RM; Sutherland DE; Simmons RL; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):473-4. PubMed ID: 7022876
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection.
    Kountz SL; Rao TK; Butt KH
    Transplant Proc; 1975 Mar; 7(1):73-7. PubMed ID: 1091048
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved results of cadaver renal transplantation with azathioprine, prednisone and antilymphoblast globulin.
    Novick AC; Khauli RB; Braun WE; Steinmuller D; Cunningham R; Buszta C; Goormastic M
    J Urol; 1984 Apr; 131(4):636-40. PubMed ID: 6368866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation.
    Henry ML; Sommer BG; Ferguson RM
    Am J Surg; 1985 Nov; 150(5):533-6. PubMed ID: 2998215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.
    Griñó JM; Castelao AM; Serón D; Gonzalez C; Galceran JM; Gil-Vernet S; Andrés E; Bover J; Torras J; Alsina J
    Transplant Proc; 1992 Feb; 24(1):39-41. PubMed ID: 1539329
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC
    Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract]   [Full Text] [Related]  

  • 11. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation.
    Griño JM; Alsina J; Sabater R; Castelao AM; Gil-Vernet S; Andres E; Sabate I; Mestre M; Seron D; Diaz C
    Transplantation; 1990 Jun; 49(6):1114-7. PubMed ID: 2360253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of antilymphocyte globulin in cadaver renal transplantation.
    Novick AC
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of chronic renal allograft rejection with cyclosporine and prednisone.
    Rosenblum ND; Harmon WE; Levey RH
    Transplantation; 1988 Jan; 45(1):232-4. PubMed ID: 3276052
    [No Abstract]   [Full Text] [Related]  

  • 14. Antirejection drugs and procedures.
    Chatterjee SN
    Am J Surg; 1973 Nov; 126(5):678-82. PubMed ID: 4129988
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement in cadaveric renal transplant survival.
    Beaudoin JG; Guttmann RD; Morehouse DD; Knaack J; Chassot PG
    Arch Surg; 1973 Aug; 107(2):245-9. PubMed ID: 4578273
    [No Abstract]   [Full Text] [Related]  

  • 16. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

  • 17. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of high doses of soluble Urbason in the treatment of renal transplants].
    Cucchiara G; Alfani D; Antonacci V; Berloco P; Famulari A; Sturniolo A; Rizzo F
    Minerva Med; 1980 Feb; 71(4):269-72. PubMed ID: 6986588
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of ATG in treatment of steroid-resistant rejection.
    Hardy MA; Nowygrod R; Elberg A; Appel G
    Transplantation; 1980 Feb; 29(2):162-4. PubMed ID: 6986690
    [No Abstract]   [Full Text] [Related]  

  • 20. Medroxyprogesterone antilymphocyte globulin, prednisone, and azathioprine in the treatment of dog renal allografts.
    MacDonald AS; Alexander JL; Busch GJ; Murray JE
    Surg Forum; 1969; 20():306-7. PubMed ID: 4192215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.